ENTRESTO 6 mg/6 mg, granules in a capsule to be opened 60 capsules
Active ingredients: COMPLEXE SODIQUE SACUBITRIL VALSARTAN HÉMIPENTAHYDRATÉ, Sacubitril, Valsartan
Commercialized according to BDPMDispensing in France: Prescription only
Granules in capsules60 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ENTRESTO 6 mg/6 mg, granulés en gélule à ouvrir
- Pharmaceutical form
- granulés en gélule
- Route of administration
- orale
- Presentation description
- plaquette(s) polyamide aluminium PVC de 60 gélule(s)
- Marketing authorisation holder
- NOVARTIS EUROPHARM (IRLANDE)
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 15 Jul 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66421822CIP73027712CIP133400930277126Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| VALSARTANgranulés | 6,4 mg · une gélule | FT |
| COMPLEXE SODIQUE SACUBITRIL VALSARTAN HÉMIPENTAHYDRATÉgranulés | — | SA |
| SACUBITRILgranulés | 6,1 mg · une capsule | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.